• Blog
  • 3D Bioprinting Market Analysis | 2023-28

    3D Bioprinting Market Analysis | 2023-28

    3D Bioprinting Market Analysis | 2023-28
    Report code - SR1227 Delivery - 2 Weeks
    3D Bioprinting Market Size, Share, Trend, Forecast, Industry Analysis & Opportuni See more...

    Market Insights

    The global 3D bioprinting market size was valued at USD 1.5 billion in 2022 and is forecast to grow to USD 4.44 billion by 2028 at a CAGR of 19.82% during 2023-2028.

    Want to know more about the market scope? Register Here

    What is 3D Bioprinting?

    3D bioprinting is a form of additive manufacturing that utilizes 3D printing to fabricate biomedical parts that maximally imitate natural tissue characteristics. This printing utilizes the layer-by-layer method to deposit materials called bio-inks, to create tissue-like structures which are later used in tissue and medical engineering fields.

    Global 3D Bioprinting Market Report Overview

    Market Size in 2028

    USD 4.44 billion

    Market Size in 2022

    USD 1.5 billion

    CAGR (2023-2028)

    19.82%

    Base Year of Study

    2022

    Trend Period

    2018-2022

    Forecast Period

    2023-2028

    Market Dynamics

    The limited number of organ donors and an increasingly senior population with chronic respiratory diseases are expected to boost the demand for 3D bioprinting market

    Some other factors augmenting the market growth are-

    • There is a growing need for organ transplants, with the use of 3D bioprinting, it may be possible to produce organs and tissues that are unique to a patient. The advancement of 3D bioprinting technology has seen a rise in financial support and research for the development of 3D bioprinting.
    • The development of new 3D printing materials, software, and hardware have made it possible to print biological materials in greater detail and accuracy.
    • The opportunity for 3D bioprinting to transform patient care has led to increasing interest in the healthcare sector. In addition, this has the potential to develop personalized medicine, and a reduction in animal experimentation is another benefit of the technology.
    • Increasing Interest of Investors, private businesses, governments, and academic institutions have all made considerable investments in the 3D bioprinting sector. 

    Moreover, a surge in public and private funding to support bioprinting research activities further offers immense growth opportunities to the industry players in the coming years.

    Segmentation

     

    3D bioprinting market: Application Trends

    The widespread use of prescription tablets to treat a variety of chronic ailments is driving the expansion of the global 3D bioprinting market. Furthermore, the increased need for medications and the cost-effective application of bio-drugs employing this technology is propelling the industry forward.

    The demand for medical pills is rising as the number of pharmaceutical sector participants grows. Millions of individuals throughout the world utilize capsules and medical pills regularly. As a result, this category is likely to increase at a rapid pace over the forecast period.

    Click Here, to learn the market segmentation details.

    3D bioprinting market: Component Trends

    The market is classified into,3D Bioprinter, Biomaterial, and Scaffolds. 3D Bioprinters accounted for the largest market share during the forecast period. Factors such as technological advancements and growing demand for organ transplants are driving the growth of the market.

    3D bioprinting market: Technology Trends

    The 3D bioprinting market is classified into inkjet-based, magnetic levitation, syringe-based, laser-based, and others. Inkjet-based segment share more than 35% in 2022, magnetic levitation segment is projected to expand with the fastest CAGR of nearly 14% during the forecast period. This is mainly ascribed to its ability to print complex living organs or tissues on the culture substrates with the help of biomaterials, such as bio-inks, which bolsters segment growth.

    3D bioprinting market: Regional Analysis

    North America shares more than 30% in 2022 and is expected to lead throughout the forecast period and Asia Pacific is the fastest-growing market with shares of more than 20% in 2022. This is mainly attributed to a growing demand for 3D bioprinting as this technology has been reconnoitered for drug testing and organ transplantation. Also, the highly advanced healthcare industry, presence of major market players, robust research & development infrastructure, growing awareness of 3D Bioprinting, and technological developments in the region, further proliferate the regional market growth.

    Want to know which region offers the best growth opportunities? Register Here

    Key Players

    Top players operating in the global 3D bioprinting market are-

    COVID-19 Impact

    The COVID-19 outbreak has positively influenced the 3D bioprinting industry. The pandemic has turned the lives of people worldwide, with the number of cases increasing rapidly. The pandemic resulted in an increasing number of coronavirus patients across the globe, putting a strain on the healthcare sector with limited hospital staff. Hence, as a reaction to the increasing cases of coronavirus, several 3D bioprinting companies are responding to the crises by offering their respective skills to ease the burden on the supply chain and governments. Due to the ever-increasing COVID-19 cases, the demand for 3D bioprinters is surging and the market for 3D bioprinting.

    Report Features

    This report provides intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the dynamics and will enable strategic decision-making for the existing players and those willing to enter the market.

    What Deliverables will you get in this report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the global 3D bioprinting market 

    How lucrative is the future?

    The market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    Which are the top players and what is their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirements?

    10% free customizations

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    3D bioprinting is a form of additive manufacturing that utilizes 3D printing to fabricate biomedical parts that maximally imitate natural tissue characteristics. This printing utilizes the layer-by-layer method to deposit materials called bioinks, to create tissue-like structures which are later used in tissue and medical engineering fields.

    The market is likely to grow at a healthy CAGR of 19.82% during the forecast period.

    The market is likely to grow from USD 1.5 Billion in 2022 to reach USD 4.44 billion by 2028

    3D Systems Corporation (US), Aspect Biosystems Ltd (Canada), GeSIM GmbH (Germany), Allevi Inc. (US), Cyfuse Biomedical KK (Japan), Envision TEC GmbH (Germany), Organovo Holdings Inc. (US), RegenHU SA (Switzerland), Stratasys Ltd (US), REGEMAT 3D (Spain) are the key players in the market.

    Inkjet-based segment share more than 35% in 2022, magnetic levitation segment is projected to expand with the fastest CAGR of nearly 14% during the forecast period.

    North America shares more than 30% in 2022 and is expected to lead throughout the forecast period.

    There is a growing need for organ transplants, with the use of 3D bioprinting, it may be possible to produce organs and tissues that are unique to a patient. The advancement of 3D bioprinting technology has seen a rise in financial support and research for the development of 3D bioprinting. The development of new 3D printing materials, software, and hardware has made it possible to print biological materials in greater detail and accuracy. The opportunity for 3D bioprinting to transform patient care has led to increasing interest in the healthcare sector. In addition, this has the potential to develop personalized medicine, and a reduction in animal experimentation is another benefit of the technology. Increasing Interest of Investors, private businesses, governments, and academic institutions have all made considerable investments in the 3D bioprinting sector.

    The study period of the market is 2018-2028.